OCWP
ADPT icon

Owl Creek Wealth Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Owl Creek Wealth Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.37K Hold
437
– – ﹤0.01% 868
2026
Q1 		$6.07K Buy
+437
New +$6.96K ﹤0.01% 922

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Owl Creek Wealth Partners's ADPT Position: Q2 2026 in Review

Owl Creek Wealth Partners held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 437 shares worth $9.37K. The position accounts for ﹤0.01% of the portfolio, ranked #868.

Owl Creek Wealth Partners first reported a position in ADPT in Q1 2026 and has held it in 2 quarters since. 280 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Owl Creek Wealth Partners held 437 shares of Adaptive Biotechnologies worth $9.37K as of Q2 2026.
  • Owl Creek Wealth Partners left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #868 holding.
  • Owl Creek Wealth Partners first reported a position in Adaptive Biotechnologies in Q1 2026 and has held it in 2 quarters since.
  • 280 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.